Astec Lifesciences Stock Screener | Share Price & Fundamental Analysis
ASTEC
Pesticides & Agrochemicals
Screen Astec Lifesciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹687.60
▼
-6.80 (-0.98%)
Share Price BSE
₹690.30
▼
-3.85 (-0.55%)
Market Cap
₹1,569.30 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.79
EPS (TTM)
₹-68.71
Dividend Yield
-
Debt to Equity
1.74
52W High
₹1115.85
52W Low
₹612.55
Operating Margin
5.00%
Profit Margin
-13.33%
Revenue (TTM)
₹120.00
EBITDA
₹6.00
Net Income
₹-16.00
Total Assets
₹881.00
Total Equity
₹235.00
Astec Lifesciences Share Price History - Stock Screener Chart
Screen ASTEC historical share price movements with interactive charts. Analyze price trends and patterns.
Astec Lifesciences Company Profile - Fundamental Screener
Screen Astec Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTEC shares.
Sector
Chemicals
Industry
Pesticides & Agrochemicals
Sub-Sector
Pesticides & Agrochemicals
Segment
E
ISIN
INE563J01010
Astec Lifesciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ASTEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 881 | 975 | 979 | 897 | 678 | 572 | 461 | 413 | 334 | 330 |
| Current Assets | 341 | 399 | 499 | 516 | 330 | 332 | 249 | 232 | 198 | 191 |
| Fixed Assets | 499 | 386 | 319 | 340 | 213 | 194 | 167 | 115 | 103 | 95 |
| Liabilities | ||||||||||
| Total Liabilities | 881 | 975 | 979 | 897 | 678 | 572 | 461 | 413 | 334 | 330 |
| Current Liabilities | 281 | 208 | 34 | 10 | 46 | 7 | 10 | 5 | 2 | 9 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 235 | 370 | 420 | 397 | 309 | 247 | 203 | 170 | 138 | 118 |
| Share Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Reserves & Surplus | 215 | 350 | 400 | 377 | 290 | 227 | 183 | 150 | 119 | 99 |
Screen ASTEC income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 120 | 92 | 75 | 156 | 70 | 101 | 96 | 130 | 145 | 112 | 52 | 279 | 187 | 204 | 121 |
| Expenses | 114 | 102 | 80 | 141 | 116 | 118 | 100 | 122 | 140 | 114 | 69 | 207 | 159 | 167 | 105 |
| EBITDA | 6 | -11 | -6 | 15 | -45 | -18 | -4 | 8 | 5 | -2 | -17 | 72 | 28 | 37 | 16 |
| Operating Profit % | 5.00% | -12.00% | -9.00% | 8.00% | -67.00% | -20.00% | -6.00% | 4.00% | 2.00% | -3.00% | -36.00% | 24.00% | 14.00% | 17.00% | 10.00% |
| Depreciation | 12 | 12 | 10 | 9 | 9 | 12 | 11 | 8 | 9 | 9 | 9 | 11 | 9 | 8 | 9 |
| Interest | 10 | 11 | 8 | 7 | 7 | 9 | 10 | 6 | 7 | 6 | 6 | 3 | 4 | 5 | 6 |
| Profit Before Tax | -16 | -33 | -24 | -1 | -62 | -39 | -25 | -6 | -11 | -18 | -32 | 58 | 15 | 25 | 1 |
| Tax | 0 | 0 | 0 | 0 | -22 | 0 | 15 | -1 | -3 | -4 | -8 | 15 | 4 | 6 | 0 |
| Net Profit | -16 | -33 | -24 | -1 | -40 | -39 | -40 | -5 | -8 | -13 | -24 | 43 | 11 | 18 | 1 |
| EPS | -8.20 | -16.85 | -11.35 | -0.50 | -20.26 | -19.66 | -20.59 | -2.54 | -4.18 | -6.85 | -12.41 | 21.97 | 5.82 | 9.34 | 0.43 |
Astec Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen ASTEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 10 | 75 | 24 | -8 | 168 | 15 | 65 | 19 | -13 |
| Investing Activities | -15 | -135 | -113 | -104 | -73 | -74 | -53 | -49 | -18 | -17 |
| Financing Activities | 24 | 125 | 38 | 81 | 81 | -95 | 37 | -18 | -1 | 31 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 1 | 2 |
Screen ASTEC shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jul | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.42% | 72.42% | 70.87% | 70.87% | 66.75% | 66.75% | 66.75% | 66.75% |
| FII Holding | 0.00% | 0.02% | 0.02% | 0.25% | 1.20% | 0.53% | 1.03% | 1.25% |
| DII Holding | 4.01% | 4.01% | 4.26% | 4.34% | 5.41% | 4.51% | 3.38% | 7.88% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.32% | 18.96% | 19.98% | 19.62% | 20.71% | 21.95% | 22.52% | 19.62% |
| Other Holding | 4.25% | 4.59% | 4.87% | 4.91% | 5.93% | 6.26% | 6.33% | 4.49% |
| Shareholder Count | 18,276 | 18,889 | 18,549 | 18,689 | 19,057 | 19,727 | 19,955 | 19,848 |
Astec Lifesciences Dividend Screener - Share Yield Analysis
Screen ASTEC dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.50 | 0.14% |
| 2022-March | ₹1.50 | 0.11% |
| 2021-March | ₹1.50 | 0.09% |
| 2020-March | ₹1.50 | 0.15% |
| 2019-March | ₹1.50 | 0.39% |
| 2018-March | ₹1.50 | 0.28% |
| 2017-March | ₹1.50 | 0.26% |
| 2016-March | ₹0.00 | 0.00% |
Astec Lifesciences Index Membership - Market Screener Classification
Screen ASTEC by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Astec Lifesciences Market Events Screener - Corporate Actions
Screen ASTEC market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-10-29 | 2025-10-29 | Quarterly Result Announcement | NA | -8.59% |
| 2025-07-28 | 2025-07-28 | Annual General Meeting | NA | 18.90% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 0.28% |
| 2025-07-04 | 2025-07-04 | Rights | 1:7 | 1.17% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 8.19% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | -5.28% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -2.44% |
| 2024-07-29 | 2024-07-29 | Annual General Meeting | NA | -0.39% |
| 2023-07-27 | 2023-07-27 | Annual General Meeting | NA | -6.24% |
| 2023-07-21 | 2023-07-22 | Dividend | ₹ 1.50 /share | -3.11% |
| 2022-07-19 | 2022-07-21 | Dividend | ₹ 1.50 /share | 13.14% |
| 2021-07-22 | 2021-07-24 | Dividend | ₹ 1.50 /share | 18.78% |
Astec Lifesciences Competitors Screener - Peer Comparison
Screen ASTEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 66,398 | 27.42 | 47,123 | 8.13% | 820 | 65.11 |
| PI Industries | 48,306 | 32.45 | 8,322 | 5.70% | 1,660 | 30.96 |
| Sumitomo Chemical | 23,133 | 42.68 | 3,269 | 11.19% | 506 | 51.30 |
| Bayer Crop Science | 20,287 | 33.47 | 5,593 | 7.89% | 568 | 51.56 |
| Sharda Cropchem | 7,576 | 16.78 | 4,379 | 35.89% | 304 | 42.23 |
| Rallis | 5,399 | 31.33 | 2,631 | 6.54% | 164 | 60.80 |
| Dhanuka Agritech | 5,310 | 18.30 | 2,071 | 15.49% | 297 | 34.21 |
| NACL Industries | 3,735 | -54.47 | 1,243 | -30.48% | -92 | 43.92 |
| Bharat Rasayan | 3,697 | 28.02 | 1,199 | 12.53% | 141 | 32.89 |
| Bhagiradha Chemicals & Industries | 2,905 | 242.87 | 450 | 9.63% | 14 | 39.62 |
Astec Lifesciences Company Announcements - News Screener
Screen ASTEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Closure of Trading Window | View |
| 2025-12-15 | Intimation Of Appointment Of Senior Management Personnel | View |
| 2025-11-07 | Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-11-07 | Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-07 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-07 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-10-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-10-29 | Statement Of Deviation And Variation For The Quarter And Half- Year Ended September 30 2025 | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-29 | Financial Result For The Quarter And Half-Year Ended September 30 2025. | View |
| 2025-10-29 | Board Meeting Outcome for Revised Outcome | View |
| 2025-10-29 | Financial Result For The Quarter And Half-Year Ended September 30 2025. | View |
| 2025-10-29 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-24 | Change In Senior Management Personnel | View |
| 2025-10-14 | Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 After These Results Are Reviewed By The Audit Committee | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-06 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |